title: Payers, providers weigh value of some costly biologics.
authors.affiliation: JCarroll@ManagedCareMag.com
authors.forename: John
authors.initials: J
authors.lastname: Carroll
mesh_terms: D001688:Biological Products / Q000191:economics*; D008329:Managed Care Programs / Q000191:economics*; D016019:Survival Analysis; D014481:United States
chemical_list: D001688:Biological Products